# FDA Inspection 1300144 - Novartis Pharmaceuticals Corporation - February 06, 2026

Source: https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/dda9986d-7403-4915-9abe-66007c22736d
Source feed: FDA_Inspections

> FDA Inspection 1300144 for Novartis Pharmaceuticals Corporation on February 06, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1300144
- Company Name: Novartis Pharmaceuticals Corporation
- Inspection Date: 2026-02-06
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1245942 - 2024-08-08](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/d2f19248-2be2-424d-85b3-a50251928268)
- [FDA Inspection 1194474 - 2022-12-09](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/016e211c-c215-46cc-85fd-3d8c24f49500)
- [FDA Inspection 1194474 - 2022-12-09](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/323eee52-83d8-45f8-91b5-c1c3e4f83f89)
- [FDA Inspection 1100101 - 2019-08-21](https://www.globalkeysolutions.net/records/fda_inspections/novartis-pharmaceuticals-corporation/e4fab4a0-2d49-44f2-a6c8-f6170fd44cd2)

Company: https://www.globalkeysolutions.net/companies/novartis-pharmaceuticals-corporation/21559fd5-35ed-4cbd-b228-623dd76bcf47

Office: https://www.globalkeysolutions.net/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248